 | • レポートコード：MRC2303K147 • 出版社/出版日：Mordor Intelligence / 2023年2月 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：実験機器 |
| Single User | ￥712,500 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,312,500 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の調査レポートでは、世界の生命科学器具市場規模が、予測期間中、CAGR 7.5％で増大すると予測されています。本レポートでは、生命科学器具の世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、種類別（器具、消耗品、サービス）分析、技術別（PCR・qPCR、サンガーシーケンス、フローサイトメトリー、核酸マイクロアレイ、その他）分析、用途別（プロテオミクス技術、ゲノム技術、セルバイオロジー技術、その他）分析、エンドユーザー別（研究所、診断研究所、その他）分析、地域別（アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン）分析、競争状況、市場機会・将来動向などについて調査・分析などの項目を掲載しています。並び、こちらのレポートには、Becton, Dickinson and Company、Agilent Technologies Inc.、Illumina Inc.、Thermo Fisher Scientific Inc.、F. Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc.、Merck KGaA、GE Healthcare、Bruker Corporation、Qiagen NV、Danaher Corporation、Abbott Laboratories Inc.などの企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の生命科学器具市場規模：種類別 - 器具の市場規模 - 消耗品の市場規模 - サービスの市場規模 ・世界の生命科学器具市場規模：技術別 - PCR・qPCR法器具の市場規模 - サンガーシーケンス法器具の市場規模 - フローサイトメトリー法器具の市場規模 - 核酸マイクロアレイ法器具の市場規模 - その他生命科学器具の市場規模 ・世界の生命科学器具市場規模：用途別 - プロテオミクス技術における市場規模 - ゲノム技術における市場規模 - セルバイオロジー技術における市場規模 - その他用途における市場規模 ・世界の生命科学器具市場規模：エンドユーザー別 - 研究所における市場規模 - 診断研究所における市場規模 - その他エンドユーザーにおける市場規模 ・世界の生命科学器具市場規模：地域別 - 北米の生命科学器具市場規模 アメリカの生命科学器具市場規模 カナダの生命科学器具市場規模 メキシコの生命科学器具市場規模 … - ヨーロッパの生命科学器具市場規模 ドイツの生命科学器具市場規模 イギリスの生命科学器具市場規模 フランスの生命科学器具市場規模 … - アジア太平洋の生命科学器具市場規模 中国の生命科学器具市場規模 日本の生命科学器具市場規模 インドの生命科学器具市場規模 … - 南米/中東の生命科学器具市場規模 南アフリカの生命科学器具市場規模 ブラジルの生命科学器具市場規模 アルゼンチンの生命科学器具市場規模 … ・競争状況 ・市場機会・将来動向 |
The life science tools market is expected to record a CAGR of 7.5% during the forecast period.
Globally, the COVID-19 pandemic positively impacted the growth of the life science tools market with the rapid development of diagnostics, fast-tracked regulatory clearances, and increased distribution in various countries to help curb the spread of the virus. Various diagnostic procedures have always been essential in the detection of infectious diseases. Currently, several molecular assays and immunoassays are in place to detect COVID-19. However, in the aftermath of the pandemic, there has been increased research in the life sciences industry to prepare for any unexpected global pandemic burden. For instance, in September 2022, the WHO issued a guidance framework for the responsible use of life science tools. The Framework calls on leaders and other stakeholders to mitigate risks and safely govern dual-use research, which has a clear benefit but can be misused to harm humans, other animals, agriculture, and the environment. Hence, with the increasing focus on life science, the market studied is expected to grow significantly in the coming years.
Genomic technologies are increasingly being used globally to understand and contribute to developing new diagnostic tests or procedures for various diseases, boosting the market’s growth. For instance, in September 2022, Becton, Dickinson, and Company (BD) and CerTest Biotec commercially launched their new molecular polymerase chain reaction (PCR) assay for the monkeypox virus for the US and global markets. The company has stated that this PCR assay will only be available for research purposes. With such new launches, the market is expected to witness strong growth over the forecast period.
Furthermore, technological advancements associated with sequencing technologies, chromatography methods, mass spectrometry, and other products led to the increasing adoption of these tools in hospitals, research labs, and diagnostic laboratories. According to the WHO 2021 Factsheet, 680,000 people died from HIV-related causes, and 1.5 million people acquired HIV. Thus, a high patient population will boost the demand for treatment and further increase the use of life sciences tools for identifying, diagnosing, and monitoring the progression of several infectious diseases.
Furthermore, the rising demand for diagnostic tests for a variety of infectious diseases will spur the development of life science tools for diagnosing the target population, propelling overall market growth over the forecast period.
Life Science Tools Market Trends
Life Science Tools in Separation Technologies is Estimated to Witness a Healthy Growth Rate Over the Forecast Period
The major factors driving the separation technologies segment include growing investments in pharmaceutical R&D and the increasing adoption of chromatography technologies by the life sciences industries.
Globally, the COVID-19 pandemic positively impacted the life science instruments market. The outbreak of COVID-19 resulted in an increased number of diseases, which led to a subsequent increase in research and development activities. Increasing investment in drug discovery is expected to fuel the growth of the separation technology segment. For example, in May 2022, Cipla announced the commercialization of its COVID-19 PCR kit in India. The real-time RT-PCR test kit has been validated by an Indian Council of Medical Research (ICMR)-approved center.
Separation technologies include immunoprecipitation, chromatographic techniques, automated purification systems, and others that aid in diagnosing and treating COVID-19. For example, according to the Indian Journal of Medical Research 2021, a study was conducted in a tertiary care teaching hospital in northern India to assess a rapid immunoassay-based chromatographic test in the diagnosis of COVID-19. The results of the study showed that immunoassay-based rapid chromatographic tests can help in the rapid detection, isolation, and treatment of patients with COVID-19.
In addition, this technology is widely adopted by several industries due to several advantages associated with chromatography technology. Benefits such as reducing the need for large columns increase the efficiency and productivity of the production process. Thus, increased adoption of multiple separation technologies across sectors would increase the demand for life science tools and drive segment growth.
The increasing prevalence of infectious diseases worldwide will encourage the adoption of life science tools. For example, according to the WHO 2021 Factsheet, 1.5 million people died of tuberculosis in 2021, and an estimated 10 million people contracted tuberculosis (TB) worldwide. It has been steadily declining in recent years. However, it is still at a much higher level.
Thus, the above-mentioned factors are expected to drive segment growth over the forecast period.
North America is Expected to Hold a Significant Market Share over the Forecast Period
The major factors driving market growth in North America include the rising number of genomic procedures, increasing research and development expenditure, the presence of a large number of major players, growing adoption among biopharmaceutical companies, product launches, and technological advancements.
With the outbreak of COVID-19 in the United States, there has been an increase in the number of diagnostic procedures, leading to market growth. Thus, diagnostic procedures with new technologies have proven beneficial in managing COVID-19 and are driving the growth of the life sciences instruments market.
The biopharmaceutical industry in the United States has expanded significantly to include new product types such as synthetic vaccines, nanoantibodies, rDNA, fusion proteins, immunoconjugates, soluble receptors, and immunotherapeutics. The pharmaceutical and biopharmaceutical industries’ increased R&D investment in life science tools, research, and academics is expected to drive the market.
For example, according to the Pharmaceutical Research and Manufacturers of America (PhRMA), the US biopharmaceutical industry is one of the world leaders in new drug development. The entire biopharmaceutical and pharmaceutical industry invested an estimated USD 91.1 billion in research and development (R&D) in 2021, compared to about USD 83 billion invested in research and development (R&D) in the previous year.
Furthermore, the increasing adoption of novel drug delivery systems and the rising prevalence of infectious disease cases are expected to fuel the life science tools market in the region over the forecast period.
Life Science Tools Market Competitor Analysis
The life science tools market is moderately competitive. The market players adopted strategies such as product approval and launches, acquisitions, partnerships, and agreements. Some of the market players include Becton, Dickinson and Company, Agilent Technologies, Illumina Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Merck KGaA, GE Healthcare, and Bruker QIAGEN.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in Demand for Biopharmaceuticals and Increasing Funding for Life Science Research
4.2.2 Rising Incidence of Target Infectious Diseases and Genetic Disorders
4.3 Market Restraints
4.3.1 High Cost of Instruments
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Type
5.1.1 Instruments
5.1.2 Consumables
5.1.3 Services
5.2 By Technology
5.2.1 PCR and qPCR
5.2.2 Sanger Sequencing
5.2.3 Separation Technologies
5.2.4 Flow Cytometry
5.2.5 Nucleic Acid Microarray
5.2.6 Mass Spectrometry
5.2.7 Other Technologies
5.3 By Application
5.3.1 Proteomics Technology
5.3.2 Genomic Technology
5.3.3 Cell Biology Technology
5.3.4 Other Applications
5.4 By End User
5.4.1 Research Laboratories
5.4.2 Diagnostic Laboratories
5.4.3 Other End Users
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Becton, Dickinson and Company
6.1.2 Agilent Technologies Inc.
6.1.3 Illumina Inc.
6.1.4 Thermo Fisher Scientific Inc.
6.1.5 F. Hoffmann-La Roche Ltd
6.1.6 Bio-Rad Laboratories Inc.
6.1.7 Merck KGaA
6.1.8 GE Healthcare
6.1.9 Bruker Corporation
6.1.10 Qiagen NV
6.1.11 Danaher Corporation
6.1.12 Abbott Laboratories Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS